(0.13%) 5 187.37 points
(0.06%) 38 876 points
(-0.03%) 16 345 points
(0.20%) $78.64
(0.68%) $2.21
(-0.31%) $2 324.00
(-0.32%) $27.53
(2.42%) $988.25
(0.16%) $0.930
(0.86%) $10.92
(0.44%) $0.799
(-0.03%) $91.32
-3.85% $ 0.375
Live Chart Being Loaded With Signals
Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia...
Stats | |
---|---|
Dzisiejszy wolumen | 144 537 |
Średni wolumen | 131 618 |
Kapitalizacja rynkowa | 78.50M |
EPS | $0 ( 2024-02-27 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -9.37 |
ATR14 | $0.00100 (0.27%) |
Orthocell Ltd Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Orthocell Ltd Finanse
Annual | 2023 |
Przychody: | $4.24M |
Zysk brutto: | $3.06M (72.13 %) |
EPS: | $-0.0317 |
FY | 2023 |
Przychody: | $4.24M |
Zysk brutto: | $3.06M (72.13 %) |
EPS: | $-0.0317 |
FY | 2022 |
Przychody: | $1.53M |
Zysk brutto: | $832 517 (54.35 %) |
EPS: | $-0.0468 |
FY | 2021 |
Przychody: | $1.02M |
Zysk brutto: | $392 317 (38.54 %) |
EPS: | $-0.0528 |
Financial Reports:
No articles found.
Orthocell Ltd
Orthocell Limited, a regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia. The company offers CelGro, a naturally derived collagen medical device for use in multiple indications to augment the surgical repair of bone, peripheral nerves, tendons, and cartilage; and Ortho-ATI, a cell therapy for treatment of chronic tendon injuries. It also provides Ortho-ACI, an autologous chondrocyte implantation to treat articular cartilage defects in the knee and ankle; Striate+, a resorbable collagen membrane used for guided bone and tissue regeneration in dental application; and Remplir, a collagen scaffold used in peripheral nerve repair. Orthocell Limited was incorporated in 2006 and is headquartered in Murdoch, Australia.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej